Authors:
KIIVET RA
BERGMAN U
ROOTSLANE L
RAGO L
SJOQVIST F
Citation: Ra. Kiivet et al., DRUG-USE IN ESTONIA IN 1994-1995 - A FOLLOW-UP FROM 1989 AND COMPARISON WITH 2 NORDIC COUNTRIES, European Journal of Clinical Pharmacology, 54(2), 1998, pp. 119-124
Authors:
MARANDI T
DAHL ML
KIIVET RA
RAGO L
SJOQVIST F
Citation: T. Marandi et al., DEBRISOQUIN AND S-MEPHENYTOIN HYDROXYLATION PHENOTYPES AND CYP2D6 GENOTYPES IN AN ESTONIAN POPULATION, Pharmacology & toxicology, 78(5), 1996, pp. 303-307
Authors:
KIIVET RA
LLERENA A
DAHL ML
ROOTSLANE L
VEGA JS
EKLUNDH T
SJOQVIST F
Citation: Ra. Kiivet et al., PATTERNS OF DRUG-TREATMENT OF SCHIZOPHRENIC-PATIENTS IN ESTONIA, SPAIN AND SWEDEN, British journal of clinical pharmacology, 40(5), 1995, pp. 467-476
Authors:
KIIVET RA
BIBA V
ENACHE D
FOLTAN V
GULBINOVIC J
OLTVANYI N
ORAZEM A
POPOVA M
STIKA L
Citation: Ra. Kiivet et al., CHANGES IN THE USE OF ANTIBACTERIAL DRUGS IN THE COUNTRIES OF CENTRALAND EASTERN-EUROPE, European Journal of Clinical Pharmacology, 48(3-4), 1995, pp. 299-304
Citation: A. Llerena et Ra. Kiivet, FIXED COMBINATIONS OF NEUROLEPTICS WITH ANTIDEPRESSANTS - POTENTIAL RISKS AND ESTIMATION OF USE, British journal of clinical pharmacology, 37(6), 1994, pp. 531-532
Citation: Ra. Kiivet et L. Allikmets, POSSIBILITIES FOR FUTURE COOPERATION WITHIN THE FIELD OF RESPIRATORY PHYSIOLOGY AND PHARMACOLOGY, Pharmacology & toxicology, 72, 1993, pp. 53-55